104 related articles for article (PubMed ID: 30803715)
1. Evidence of slight improvement in five-year survival in non-small-cell lung cancer over the last 10 years: Results of the French KBP-CPHG real-world studies.
Debieuvre D; Locher C; Asselain B; Dayen C; Molinier O; Falchero L; Dujon C; Delclaux B; Grivaux M
Bull Cancer; 2019 Apr; 106(4):283-292. PubMed ID: 30803715
[TBL] [Abstract][Full Text] [Related]
2. [One-year survival improvement in lung cancer in France. Results of the prospective real life studies KBP-2000-CPHG and KBP-2010-CPHG].
Grivaux M; Duvert B; Ferrer-Lopez P; Hominal S; Goarant E; Brichet-Martin A; Romand P; Fournier E; Asselain B; Debieuvre D
Rev Pneumol Clin; 2016 May; 72(3):163-70. PubMed ID: 27113617
[TBL] [Abstract][Full Text] [Related]
3. [Ten-year evolution in non-small-cell lung cancer according to sex. Results of the KBP-2010-CPHG study by the College of General Hospital Respiratory Physicians].
Debieuvre D; Locher C; Neidhardt AC; Goupil F; Lemaire B; Blanchet-Legens AS; Renault D; Tavernier JY; Tagu P; Mahmoud H; Figueredo M; Grivaux M
Rev Mal Respir; 2014 Nov; 31(9):805-16. PubMed ID: 25433585
[TBL] [Abstract][Full Text] [Related]
4. The new face of non-small-cell lung cancer in men: Results of two French prospective epidemiological studies conducted 10 years apart.
Debieuvre D; Oster JP; Riou R; Berruchon J; Levy A; Mathieu JP; Dumont P; Leroy-Terquem E; Tizon-Couetil V; Martin F; Grivaux M
Lung Cancer; 2016 Jan; 91():1-6. PubMed ID: 26711927
[TBL] [Abstract][Full Text] [Related]
5. Major changes in lung cancer over the last ten years in France: the KBP-CPHG studies.
Locher C; Debieuvre D; Coëtmeur D; Goupil F; Molinier O; Collon T; Dayen C; Le Treut J; Asselain B; Martin F; Blanchon F; Grivaux M
Lung Cancer; 2013 Jul; 81(1):32-8. PubMed ID: 23541463
[TBL] [Abstract][Full Text] [Related]
6. [Study KBP-2010-CPHG: inclusion of new cases of primary lung cancer diagnosed in general hospital pneumology departments between 1st January and 31 December 2010].
Grivaux M; Locher C; Bombaron P; Collon T; Coëtmeur D; Dayen C; Debieuvre D; Goupil F; Le Treut J; Martin F; Molinier O; Asselain B; Zureik M; Blanchon F
Rev Pneumol Clin; 2010 Dec; 66(6):375-82. PubMed ID: 21167448
[TBL] [Abstract][Full Text] [Related]
7. [Cohort KBP-2000-CPHG: Evaluation of factors influencing survival in lung cancer].
Blanchon F; Grivaux M; Zureik M; Marsal L; Asselain B; Lebas FX; Orlando JP; Steenhouwer F; Benichou-Flurin M; Coëtmeur D; Collon T; David P; Delclaux B; Piquet J
Rev Mal Respir; 2006 Apr; 23(2 Pt 1):165-71. PubMed ID: 16788443
[TBL] [Abstract][Full Text] [Related]
8. Early mortality in lung cancer: French prospective multicentre observational study.
Grivaux M; Debieuvre D; Herman D; Lemonnier C; Marcos JM; Crequit J; Vuillermoz-Blas S; Barre P; Saillour M; Martin F
BMC Pulm Med; 2016 Apr; 16():45. PubMed ID: 27039176
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic strategies in patients undergoing surgery for non-small cell lung cancer. Results of the ESCAP-2011-CPHG study, promoted by the French College of General Hospital Respiratory Physicians (CPHG)].
Pinquié F; Goupil F; Oster JP; Dixmier A; Renault PA; Lévy A; Mathieu JP; Paillot N; Goutorbe FC; Masson P; Molinier O; Debieuvre D; Grivaux M
Rev Mal Respir; 2017 Nov; 34(9):976-990. PubMed ID: 29150179
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer among women in France. Analysis of the 904 French women with lung cancer included in the KBP-2000-CPHG study of the French College of General Hospital-based Pneumologists (CPHG).
Grivaux M; Breton JL; Bombaron P; Kuntz P; Lebas FX; Mehdaoui A; Herman D; David P; Berruchon J; Delclaux B; Zureik M; Blanchon F;
Lung Cancer; 2004 Sep; 45(3):279-87. PubMed ID: 15301868
[TBL] [Abstract][Full Text] [Related]
11. Five-year survival for lung cancer patients managed in general hospitals.
Grivaux M; Zureik M; Marsal L; Asselain B; Peureux M; Chavaillon JM; Prudhomme A; Carbonnelle M; Goarant E; Maury B; Bedossa A; Blanchon F
Rev Mal Respir; 2011 Sep; 28(7):e31-8. PubMed ID: 21943545
[TBL] [Abstract][Full Text] [Related]
12. Impact of distance from surgery department on the outcome of patients followed for non-small-cell lung cancer in the respiratory department of nonacademic hospitals: Results of the KBP-2010-study.
Debieuvre D; Fraboulet G; Duvert B; Piquet J; Goarant E; Sandron D; Mouroux-Rotomondo C; Borrel B; Genety C; Kassem GJ; Grivaux M
Bull Cancer; 2017 Oct; 104(10):840-849. PubMed ID: 28965729
[TBL] [Abstract][Full Text] [Related]
13. [Five year survival for lung cancer patients managed in general hospitals].
Grivaux M; Zureik M; Marsal L; Asselain B; Peureux M; Chavaillon JM; Prud'homme A; Carbonnelle M; Goarant E; Maury B; Bedossa A; Blanchon F
Rev Mal Respir; 2009 Jan; 26(1):37-44. PubMed ID: 19212288
[TBL] [Abstract][Full Text] [Related]
14. [First treatment strategies in the 2 years following lung cancer diagnosis. ESCAP-2011-CPHG, a real-life study carried out in French general hospitals].
Grivaux M; Goupil F; Asselain B; Blanchon F; Collon T; Coëtmeur D; Dayen C; Locher C; Molinier O; Martin F; Debieuvre D
Rev Mal Respir; 2017 Nov; 34(9):991-999. PubMed ID: 29111174
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between primary lung cancer and tobacco consumption. Results of the KBP-2010-CPHG study by the French College of General Hospital Respiratory Physicians].
Coëtmeur D; Leveiller G; Frappat V; Martin M; Peureux M; Dehette S; Carbonnelle M; Dayen C; Debieuvre D; Grivaux M
Rev Mal Respir; 2016 Sep; 33(7):583-93. PubMed ID: 26621000
[TBL] [Abstract][Full Text] [Related]
16. Prediagnosis weight loss, a stronger factor than BMI, to predict survival in patients with lung cancer.
Morel H; Raynard B; d'Arlhac M; Hauss PA; Lecuyer E; Oliviero G; Marty C; Gury JP; Asselain B; Grivaux M; Debieuvre D
Lung Cancer; 2018 Dec; 126():55-63. PubMed ID: 30527193
[TBL] [Abstract][Full Text] [Related]
17. 4-year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index.
Blanchon F; Grivaux M; Asselain B; Lebas FX; Orlando JP; Piquet J; Zureik M
Lancet Oncol; 2006 Oct; 7(10):829-36. PubMed ID: 17012045
[TBL] [Abstract][Full Text] [Related]
18. Lung cancer trends and tumor characteristic changes over 20 years (2000-2020): Results of three French consecutive nationwide prospective cohorts' studies.
Debieuvre D; Molinier O; Falchero L; Locher C; Templement-Grangerat D; Meyer N; Morel H; Duval Y; Asselain B; Letierce A; Trédaniel J; Auliac JB; Bylicki O; Moreau L; Fore M; Corre R; Couraud S; Cortot A; ;
Lancet Reg Health Eur; 2022 Nov; 22():100492. PubMed ID: 36108315
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for early mortality from lung cancer: evolution over the last 20 years in the French nationwide KBP cohorts.
Hoang TCT; Debieuvre D; Bravard AS; Martinez S; Le Garff G; Jeandeau S; Petit L; Marquette D; Amrane K; Demontrond P; Tiercin M; Jarjour B; Turlotte A; Masson P; Jaafar M; Hauss PA; Morel H;
ESMO Open; 2024 Jun; 9(6):103594. PubMed ID: 38848661
[TBL] [Abstract][Full Text] [Related]
20. Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2).
Cadranel J; Mauguen A; Faller M; Zalcman G; Buisine MP; Westeel V; Longchampt E; Wislez M; Coudert B; Daniel C; Chetaille B; Michiels S; Blons H; Solassol J; De Fraipont F; Foucher P; Urban T; Lacroix L; Poulot V; Quoix E; Antoine M; Danton G; Morin F; Chouaid C; Pignon JP
J Thorac Oncol; 2012 Oct; 7(10):1490-502. PubMed ID: 22982650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
